JPMORGAN CHASE & CO - SIENNA BIOPHARMACEUTICALS IN ownership

SIENNA BIOPHARMACEUTICALS IN's ticker is SNNAQ and the CUSIP is 82622H108. A total of 24 filers reported holding SIENNA BIOPHARMACEUTICALS IN in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of SIENNA BIOPHARMACEUTICALS IN
ValueSharesWeighting
Q3 2019$0
-100.0%
804
+2.8%
0.00%
Q2 2019$1,000
-88.9%
782
-80.1%
0.00%
Q1 2019$9,000
-79.5%
3,939
-79.4%
0.00%
Q4 2018$44,000
-77.8%
19,082
+42.8%
0.00%
Q3 2018$198,000
+36.6%
13,362
+40.2%
0.00%
Q2 2018$145,000
+62.9%
9,531
+101.0%
0.00%
Q1 2018$89,000
+39.1%
4,741
+34.8%
0.00%
Q4 2017$64,000
+68.4%
3,516
+106.8%
0.00%
Q3 2017$38,0001,7000.00%
Other shareholders
SIENNA BIOPHARMACEUTICALS IN shareholders Q3 2019
NameSharesValueWeighting ↓
Omega Fund Management, LLC 758,610$1,760,0001.30%
Wildcat Capital Management, LLC 295,613$686,0000.45%
PFM Health Sciences, LP 1,576,619$3,658,0000.10%
Cohen Capital Management, Inc. 108,010$251,0000.07%
Partner Investment Management, L.P. 15,283$35,0000.04%
CLOUGH CAPITAL PARTNERS L P 136,228$316,0000.04%
Tower Research Capital LLC (TRC) 12,183$29,0000.00%
Assenagon Asset Management S.A. 69,931$162,0000.00%
Ballentine Partners, LLC 16,700$39,0000.00%
A.R.T. Advisors, LLC 10,206$24,0000.00%
View complete list of SIENNA BIOPHARMACEUTICALS IN shareholders